Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Plant Foods Hum Nutr ; 77(1): 37-43, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35292934

RESUMEN

The anti-inflammatory effects of Aloe vera (AV), polysaccharide extract from AV, and extracts from the digestion and colonic fermentation of AV were evaluated using an immortal astrocyte cell line (U373 MG) that develops a neuro-inflammatory profile. Cell viability and inflammatory markers were assessed after stimulation with neuropeptide substance P (SP) that activates the pro-inflammatory MAPK (mitogen-activated protein kinase) pathway. Cell viability after SP treatment was over 50% at 10 mg/mL AV, polysaccharide extract from AV, extracts from the digestion: non-digestible fraction of AV non-digestible fraction of polysaccharide extract from AV and extracts from the colonic fermentation of AV, at 4 and 24 h. Moreover, cells exposed to SP and treated with these extracts showed lower protein-activated ERK1/ERK2 (extracellular signal-regulated kinases 1 and 2), p38 (MAPK protein p38), and NFκB (nuclear factor κB) levels with respect to the SP-stimulated control. Inflammation inhibition by extracts of polysaccharide extract from AV and extracts from the colonic fermentation of AV, at 24 h in the study of p38 was not as statistically significant in ERK1/ERK2 and NFκB. Nevertheless, there was a significant decrease (p < 0.05) in pro-inflammatory cytokine IL-6 levels in cells exposed to all samples. Samples with extracts from the colonic fermentation of AV, at 4 or 24 h showed the highest inhibitory effect on IL-6 production.


Asunto(s)
Aloe , Astrocitoma , Glioblastoma , Aloe/química , Antiinflamatorios/farmacología , Astrocitoma/metabolismo , Glioblastoma/metabolismo , Humanos , Interleucina-6/metabolismo , FN-kappa B/metabolismo , Extractos Vegetales/farmacología , Polisacáridos/farmacología , Sustancia P/farmacología , Sustancia P/fisiología , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
2.
Neurotox Res ; 38(3): 611-625, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32623694

RESUMEN

The amyloid beta-peptide (Aß) is the low-abundance product of amyloid precursor protein (APP), which is produced lifelong in the healthy brain. The functional properties of Aß40 and Aß42 peptides have not been completely elucidated to date. Although, several studies suggest that these peptides have a number of neurotrophic and neurotoxic properties, respectively. Interestingly, low concentrations of Aß40 and Aß42 regulate synaptic plasticity and improve cognitive functions, whereas the accumulation of Aß42, coupled with the effects of age, can cause dysregulation of synaptic function, as is shown in Alzheimer's disease. Additionally, several studies suggest that both peptides, Aß40 and Aß42, are involved in neurogenic processes; however, these results are still controversial. Moreover, existing data indicate a direct relationship between the physicochemical characteristics of the peptides and their effects. Herein, we evaluated the effect of Aß40 oligomers on hippocampal precursor cells isolated from the dentate gyrus of adult female C57Bl6 mice (mADGPCs). To this end, mADGPCs were treated with nanomolar and micromolar range concentrations of oligomeric forms of Aß40 for 24, 48, and 72 h to evaluate their effects on several events in the neurogenic process in vitro, including viability, proliferation, and early differentiation. The results indicate that Aß40 favors mADGPC proliferation, survival, and neuronal differentiation following a mechanism that involves activation of the Akt signaling pathway. Thus, this study provides evidence about the positive effects of Aß40 oligomers on the neurogenic process in adult mouse hippocampal precursor cells in vitro.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Encéfalo/metabolismo , Diferenciación Celular/fisiología , Neuronas/metabolismo , Animales , Hipocampo/metabolismo , Ratones Endogámicos C57BL , Neurogénesis/fisiología , Fragmentos de Péptidos/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo
3.
Mol Nutr Food Res ; 62(16): e1800313, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29979819

RESUMEN

SCOPE: The aim of this study is to assess whether the long-term addition of genistein to a high-fat diet can ameliorate the metabolic and the cognitive alterations and whether the changes can be associated with modifications to the gut microbiota. METHODS AND RESULTS: C57/BL6 mice were fed either a control (C) diet, a high-fat (HF) diet, or a high-fat diet containing genistein (HFG) for 6 months. During the study, indirect calorimetry, IP glucose tolerance tests, and behavioral analyses were performed. At the end of the study, plasma, liver, brain, and fecal samples were collected. The results showed that mice fed the HFG diet gained less weight, had lower serum triglycerides, and an improvement in glucose tolerance than those fed an HF diet. Mice fed the HFG diet also modified the gut microbiota that was associated with lower circulating levels of lipopolysaccharide (LPS) and reduced expression of pro-inflammatory cytokines in the liver compared to those fed HF diet. The reduction in LPS by the consumption of genistein was accompanied by an improvement of the cognitive function. CONCLUSIONS: Genistein is able to regulate the gut microbiota, reducing metabolic endotoxemia and decreasing the neuroinflammatory response despite the consumption of a HF diet.


Asunto(s)
Cognición/efectos de los fármacos , Endotoxemia/prevención & control , Microbioma Gastrointestinal/efectos de los fármacos , Genisteína/administración & dosificación , Glucosa/metabolismo , Animales , Dieta Alta en Grasa , Homólogo 4 de la Proteína Discs Large/análisis , Metabolismo Energético , Inflamación/prevención & control , Lípidos/sangre , Lipopolisacáridos/sangre , Masculino , Ratones , Ratones Endogámicos C57BL , Aumento de Peso
4.
Biol Trace Elem Res ; 152(3): 367-72, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23400904

RESUMEN

Fluoride compounds are abundant and widely distributed in the environment at a variety of concentrations. Further, fluoride induces toxic effects in target organs such as the liver and kidney. In this study, we performed an early analysis of renal function using a clearance technique in Wistar rats acutely exposed to fluoride at a plasma concentration of 0.625 µg/ml. Our results revealed that fluoride, at a concentration close to the concentration present in the serum after environmental exposure, induced a significant tubular dysfunction, resulting in diluted urine, impaired protein reabsorption, and increased calcium and phosphate urinary excretion. Our work demonstrates that even acute exposures to low concentrations of NaF may induce renal damage and confirms that, after exposure, the kidney participates directly in the calcium and phosphate deficiencies observed in fluoride-exposed populations.


Asunto(s)
Agua Corporal/efectos de los fármacos , Calcio/metabolismo , Contaminantes Ambientales/toxicidad , Homeostasis/efectos de los fármacos , Riñón/efectos de los fármacos , Fosfatos/metabolismo , Fluoruro de Sodio/toxicidad , Animales , Presión Arterial/efectos de los fármacos , Calcio/sangre , Calcio/orina , Relación Dosis-Respuesta a Droga , Exposición a Riesgos Ambientales , Femenino , Pruebas de Función Renal , Tasa de Depuración Metabólica , Fosfatos/sangre , Fosfatos/orina , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA